Skip to content

REPROCELL vs TARA Biosystems

REPROCELL logo

REPROCELL

Better Translating Discoveries into Therapies

58 employees · est. 2003 · Yokohama, Japan

VS
TARA Biosystems logo

TARA Biosystems

Offering cutting-edge, mature human cardiac tissue models to accelerate the development of safe and effective new medicines

est. 2014

REPROCELL is the older company (2003 vs 2014).

Side-by-Side Comparison

REPROCELL TARA Biosystems
Founded
2003 older 2014
Headquarters
Yokohama, Japan Not tracked yet
Employees
58 Not tracked yet
Industry
Biotechnology Biotechnology
Funding Stage
Not tracked yet Series A
Total Funding
$1.99M $21.25M
Funding Rounds
6 6
Services
End-to-End Solutions for Cell Therapy, Stem Cell and Gene Editing Services, Diagnostic Development Support, Preclinical and Clinical Drug Development Support, Biospecimen and Molecular Services Not tracked yet
Target Customers
Cell Therapy Developers, Stem Cell Researchers, Diagnostic Developers, Preclinical Drug Developers, Clinical Drug Developers Not tracked yet
Taxonomy
Stem Cell ResearchPre-Clinical Drug DevelopmentHuman Tissue AccessHuman Tissue TestingStem Cell Culture MediaIPSC Reprogramming Technologies +9 Drug DiscoveryStem Cell ResearchCardiac Tissue ModelsTranslational MedicinePredictive ModelingPharmaceutical Development +5
Website
reprocell.com tarabiosystems.com
REPROCELL logo

About REPROCELL

REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes in comprehensive support for stem cell research and pre-clinical drug development. Its unique offer...

TARA Biosystems logo

About TARA Biosystems

Tara Biosystems is a biotechnology startup founded in 2014, with a strong focus on revolutionizing the development of new medicines. By utilizing cutting-edge human cardiac tissue models, the company aims to expedite the process of drug discovery and safety evaluation. The Series A investment receiv...

Also comparing in this category

Comparing more than these two?

Get REPROCELL, TARA Biosystems and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does REPROCELL compare?

A PDF of REPROCELL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

REPROCELL was founded in 2003, based in Yokohama, Japan, with 58 employees. REPROCELL, founded in 2003, operates at the forefront of the Biotechnology industry with a mission encapsulated by its slogan, "Better Translating Discoveries into Therapies." The company specializes. TARA Biosystems was founded in 2014. Tara Biosystems is a biotechnology startup founded in 2014, with a strong focus on revolutionizing the development of new medicines. By utilizing cutting-edge human cardiac tissue models, the company.
REPROCELL has raised $1.99M and TARA Biosystems $21.25M. Latest stage: TARA Biosystems Series A.
Both work in Biotechnology and list stem cell research among their focus areas.

Compare REPROCELL with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at REPROCELL on 9 Jun 2026, and TARA Biosystems on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout